Showing results (61-70 of 11,316) with videos related to

Sort By:
Pageof 1,132
Thrombosis and Haemostasis|February 11, 2000
Elevation of FVIII: C in venous thromboembolism is persistent and independent of the acute phase responseJ O'Donnell, A D Mumford, R A Manning, et al.
Thrombosis and Haemostasis|February 11, 2000
Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive diseaseW Renner, H Köppel, M Brodmann, et al.
Thrombosis and Haemostasis|February 11, 2000
A common polymorphism flanking the ATG initiator codon of GPIb alpha does not affect expression and is not a major risk factor for arterial thrombosisJ Corral, M L Lozano, R González-Conejero, et al.
Thrombosis and Haemostasis|February 11, 2000
Hemostatic parameters and platelet activation marker expression in cyanotic and acyanotic pediatric patients undergoing cardiac surgery in the presence of tranexamic acidE Levin, J Wu, D V Devine, et al.
Thrombosis and Haemostasis|February 11, 2000
Structural basis for hemophilia A caused by mutations in the C domains of blood coagulation factor VIIIA J Gale, J L Pellequer, E D Getzoff, et al.
Thrombosis and Haemostasis|February 11, 2000
A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factorK Vanhoorelbeke, N Cauwenberghs, S Vauterin, et al.
Thrombosis and Haemostasis|February 11, 2000
Platelets release their lysosomal content in vivo in humans upon activationS Ciferri, C Emiliani, G Guglielmini, et al.
Thrombosis and Haemostasis|February 11, 2000
Determination of the putative binding sites for thrombin receptor activating peptide through a hydropathic complementary approachJ Suttnar, J E Dyr, L Dolecková
Thrombosis and Haemostasis|August 26, 2000
Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapyP Aukrust, S Bjørnsen, B Lunden, et al.
Thrombosis and Haemostasis|August 26, 2000
Local and systemic effects of intra-arterial desmopressin in healthy volunteers and patients with type 3 von Willebrand disease. Role of interleukin-6D E Newby, A Stewart, F N Witherow, et al.
Pageof 1,132